Wee‐Teng Poh

689 total citations
9 papers, 528 citations indexed

About

Wee‐Teng Poh is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Wee‐Teng Poh has authored 9 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Wee‐Teng Poh's work include Carcinogens and Genotoxicity Assessment (2 papers), Cancer Risks and Factors (2 papers) and Dermatological and Skeletal Disorders (1 paper). Wee‐Teng Poh is often cited by papers focused on Carcinogens and Genotoxicity Assessment (2 papers), Cancer Risks and Factors (2 papers) and Dermatological and Skeletal Disorders (1 paper). Wee‐Teng Poh collaborates with scholars based in Singapore, Malaysia and United States. Wee‐Teng Poh's co-authors include Adeline Seow, Philip Eng, Mimi C. Yu, Ming Ming Teh, Hin-Peng Lee, Yee‐Tang Wang, Bin Zhao, Kee‐Seng Chia, Ming Teh and Hin‐Peng Lee and has published in prestigious journals such as International Journal of Cancer, Carcinogenesis and Ophthalmic Plastic and Reconstructive Surgery.

In The Last Decade

Wee‐Teng Poh

9 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wee‐Teng Poh Singapore 8 237 150 86 83 61 9 528
Z.-W. Dong China 10 170 0.7× 136 0.9× 80 0.9× 162 2.0× 50 0.8× 11 855
Bas A.J. Verhage Netherlands 20 227 1.0× 239 1.6× 95 1.1× 104 1.3× 48 0.8× 37 814
Satoshi Numoto Japan 10 186 0.8× 81 0.5× 115 1.3× 53 0.6× 35 0.6× 24 465
Neonilia Szeszenia‐Dabrowska Poland 7 217 0.9× 72 0.5× 62 0.7× 53 0.6× 43 0.7× 8 366
Liqun Jia China 14 305 1.3× 155 1.0× 76 0.9× 149 1.8× 91 1.5× 68 717
Xiu‐Di Sun China 7 214 0.9× 189 1.3× 100 1.2× 195 2.3× 131 2.1× 8 937
Megan Meyer United States 12 153 0.6× 84 0.6× 68 0.8× 119 1.4× 97 1.6× 20 533
Vali Constantinescu France 9 261 1.1× 93 0.6× 125 1.5× 120 1.4× 73 1.2× 11 533
Meenakshi Agrawal United States 14 428 1.8× 143 1.0× 199 2.3× 36 0.4× 93 1.5× 27 716
Houda Alatassi United States 16 256 1.1× 131 0.9× 86 1.0× 110 1.3× 24 0.4× 36 612

Countries citing papers authored by Wee‐Teng Poh

Since Specialization
Citations

This map shows the geographic impact of Wee‐Teng Poh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wee‐Teng Poh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wee‐Teng Poh more than expected).

Fields of papers citing papers by Wee‐Teng Poh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wee‐Teng Poh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wee‐Teng Poh. The network helps show where Wee‐Teng Poh may publish in the future.

Co-authorship network of co-authors of Wee‐Teng Poh

This figure shows the co-authorship network connecting the top 25 collaborators of Wee‐Teng Poh. A scholar is included among the top collaborators of Wee‐Teng Poh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wee‐Teng Poh. Wee‐Teng Poh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Poh, Wee‐Teng, et al.. (2012). Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of penicillamine toxicity in a Wilson's disease patient.. PubMed. 67(3). 323–5. 3 indexed citations
2.
Seow, Adeline, et al.. (2005). Joint effect of asthma/atopy and an IL-6 gene polymorphism on lung cancer risk among lifetime non-smoking Chinese women. Carcinogenesis. 27(6). 1240–1244. 43 indexed citations
3.
Wang, Yi‐Shi, Yong‐Kwang Tay, Eileen Tan, & Wee‐Teng Poh. (2005). Treatment of Kimura's disease with cyclosporine. Journal of Dermatological Treatment. 16(4). 242–244. 21 indexed citations
4.
Yip, Chee‐Chew, et al.. (2002). Orbital, Adnexal, and Unusual Systemic Involvement in Rosai-Dorfman Disease. Ophthalmic Plastic and Reconstructive Surgery. 18(3). 223–227. 18 indexed citations
5.
Seow, Adeline, Bin Zhao, Wee‐Teng Poh, et al.. (2001). Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore. Carcinogenesis. 22(4). 673–677. 34 indexed citations
6.
Seow, Adeline, Wee‐Teng Poh, Ming Teh, et al.. (2001). Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: Evidence for a protective effect of soy in nonsmokers. International Journal of Cancer. 97(3). 365–371. 89 indexed citations
7.
Zhao, Bin, Adeline Seow, Wee‐Teng Poh, et al.. (2001). Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore.. PubMed. 10(10). 1063–7. 168 indexed citations
8.
Seow, Adeline, Wee‐Teng Poh, Ming Ming Teh, et al.. (2000). Fumes from meat cooking and lung cancer risk in Chinese women.. PubMed. 9(11). 1215–21. 113 indexed citations
9.
Seow, Adeline, Bin Zhao, Wee‐Teng Poh, et al.. (1999). NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore. Carcinogenesis. 20(9). 1877–1881. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026